BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1724574)

  • 1. Fluorescent probes as tools to assess the receptor for the urokinase-type plasminogen activator on tumor cells.
    Schmitt M; Chucholowski N; Busch E; Hellmann D; Wagner B; Goretzki L; Jänicke F; Günzler WA; Graeff H
    Semin Thromb Hemost; 1991 Jul; 17(3):291-302. PubMed ID: 1724574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of human single chain urokinase to Chinese Hamster Ovary cells and cloning of hamster u-PAR.
    Fowler B; Mackman N; Parmer RJ; Miles LA
    Thromb Haemost; 1998 Jul; 80(1):148-54. PubMed ID: 9684801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin increases expression of urokinase receptor by activation of the thrombin receptor.
    Yang Z; Cohen RL; Lui GM; Lawrence DA; Shuman MA
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2254-61. PubMed ID: 7558719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
    Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
    Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
    Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
    Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
    Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
    J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
    Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O
    Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor.
    Anichini E; Fibbi G; Pucci M; Caldini R; Chevanne M; Del Rosso M
    Exp Cell Res; 1994 Aug; 213(2):438-48. PubMed ID: 8050501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.
    Fibbi G; Caldini R; Chevanne M; Pucci M; Schiavone N; Morbidelli L; Parenti A; Granger HJ; Del Rosso M; Ziche M
    Lab Invest; 1998 Sep; 78(9):1109-19. PubMed ID: 9759655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of the chondrocyte fibrinolytic balance by the drug piroxicam: relevance to the osteoarthritic process.
    Fibbi G; Serni U; Matucci A; Mannoni A; Pucci M; Anichini E; Del Rosso M
    J Rheumatol; 1994 Dec; 21(12):2322-8. PubMed ID: 7699636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope mapping of the anti-urokinase monoclonal antibody 5B4 by isolated domains of urokinase.
    Corti A; Sarubbi E; Soffientini A; Nolli ML; Zanni A; Galimberti M; Parenti F; Cassani G
    Thromb Haemost; 1989 Nov; 62(3):934-9. PubMed ID: 2480654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
    Ugwu F; Van Hoef B; Bini A; Collen D; Lijnen HR
    Biochemistry; 1998 May; 37(20):7231-6. PubMed ID: 9585535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor.
    Fibbi G; Pucci M; Grappone C; Pellegrini G; Salzano R; Casini A; Milani S; Del Rosso M
    Hepatology; 1999 Mar; 29(3):868-78. PubMed ID: 10051491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of urokinase-type plasminogen activator with its receptor rapidly induces activation of glucose transporters.
    Anichini E; Zamperini A; Chevanne M; Caldini R; Pucci M; Fibbi G; Del Rosso M
    Biochemistry; 1997 Mar; 36(11):3076-83. PubMed ID: 9115983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).
    Magdolen V; Bürgle M; de Prada NA; Schmiedeberg N; Riemer C; Schroeck F; Kellermann J; Degitz K; Wilhelm OG; Schmitt M; Kessler H
    Biol Chem; 2001 Aug; 382(8):1197-205. PubMed ID: 11592401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells.
    van der Kaaden ME; Rijken DC; Groeneveld E; van Berkel TJ; Kuiper J
    Thromb Haemost; 1995 Aug; 74(2):722-9. PubMed ID: 8585013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of urokinase-type plasminogen activator receptor on U937 cells: phorbol ester PMA induces heterogeneity.
    Hansen SH; Behrendt N; Danø K; Kristensen P
    Exp Cell Res; 1990 Apr; 187(2):255-62. PubMed ID: 2156717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.
    Schuster WA; Medcalf RL; Kruithof EK
    Endocrinology; 1993 Oct; 133(4):1724-30. PubMed ID: 8404615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells.
    Moser TL; Enghild JJ; Pizzo SV; Stack MS
    Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):867-73. PubMed ID: 7537960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens.
    Reuning U; Bang NU
    Arterioscler Thromb; 1992 Oct; 12(10):1161-70. PubMed ID: 1327097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.